Publicacións (47) Publicacións de NARMEEN MALLAH NASRALLAH

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  3. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  4. Molecular surveillance in the nirsevimab era: lessons from respiratory syncytial virus breakthrough infections

    The Lancet Infectious Diseases

  5. New Vaccines for Chronic Respiratory Patients

    Archivos de Bronconeumologia, Vol. 60, Núm. 9, pp. 565-575

  6. Nomophobia and Alcohol, Tobacco, and Cannabis Consumption in Adolescents in Galicia

    Cyberpsychology, Behavior, and Social Networking, Vol. 27, Núm. 4, pp. 261-267

  7. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  8. Primary Care Referral Delays in Oral Cancer Diagnosis: A Meta-Analysis

    Oral Diseases

  9. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

  10. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology, Vol. 32, Núm. 6, pp. 3697-3705